UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 196

Sortiert nach

High Rate of Virologic Suppression with Raltegravir plus Etravirine and Darunavir/Ritonavir among Treatment-Experienced Patients Infected with Multidrug-Resistant HIV: Results of the ANRS 139 TRIO Trial

Clinical infectious diseases, 2009-11, Vol.49 (9), p.1441-1449

2009

Volltextzugriff (PDF)

Effect of Adherence as Measured by MEMS, Ritonavir Boosting, and CYP3A5 Genotype on Atazanavir Pharmacokinetics in Treatment-Naive HIV-Infected Patients

Clinical pharmacology and therapeutics, 2012-11, Vol.92 (5), p.575-583

2012

Volltextzugriff (PDF)

Pharmacokinetics of Rifampin and Isoniazid in Tuberculosis-HIV-Coinfected Patients Receiving Nevirapine- or Efavirenz-Based Antiretroviral Treatment

Antimicrobial agents and chemotherapy, 2014-06, Vol.58 (6), p.3182-3190

2014

Volltextzugriff (PDF)

Worsening pneumonitis due to a pharmacokinetic drug–drug interaction between everolimus and voriconazole in a renal transplant patient

Journal of clinical pharmacy and therapeutics, 2015-02, Vol.40 (1), p.119-120

2015

Volltextzugriff (PDF)

Long-term efficacy of darunavir/ritonavir monotherapy in patients with HIV-1 viral suppression: week 96 results from the MONOI ANRS 136 study

Journal of antimicrobial chemotherapy, 2012-03, Vol.67 (3), p.691-695

2012

Volltextzugriff (PDF)

Influence of Alpha-1 Glycoprotein Acid Concentrations and Variants on Atazanavir Pharmacokinetics in HIV-Infected Patients Included in the ANRS 107 Trial

Antimicrobial Agents and Chemotherapy, 2010-02, Vol.54 (2), p.614-619

2010

Volltextzugriff (PDF)

Effect of coadministered HIV-protease inhibitors on tacrolimus and sirolimus blood concentrations in a kidney transplant recipients

Fundamental & clinical pharmacology, 2009-08, Vol.23 (4), p.423-425

2009

Volltextzugriff (PDF)

Population pharmacokinetic analysis for nelfinavir and its metabolite M8 in virologically controlled HIV‐infected patients on HAART

British journal of clinical pharmacology, 2005-10, Vol.60 (4), p.390-403

2005

Volltextzugriff (PDF)

In vitro effects of tacrolimus on human cytochrome P450

Fundamental & clinical pharmacology, 2002-12, Vol.16 (6), p.455-460

2002

Volltextzugriff (PDF)

Single-Dose Pharmacokinetics of Amprenavir Coadministered with Grapefruit Juice

Antimicrobial Agents and Chemotherapy, 2002-05, Vol.46 (5), p.1589-1590

2002

Volltextzugriff (PDF)

Interactions between Atazanavir-Ritonavir and Tenofovir in Heavily Pretreated Human Immunodeficiency Virus-Infected Patients

Antimicrobial Agents and Chemotherapy, 2004-06, Vol.48 (6), p.2091-2096

2004

Volltextzugriff (PDF)

Therapeutic drug monitoring of methadone in HIV-infected patients receiving protease inhibitors

AIDS (London), 1998-12, Vol.12 (18), p.2510-2511

1998

Volltextzugriff (PDF)

Simultaneous high-performance liquid chromatographic determination of the antiretroviral agents amprenavir, nelfinavir, ritonavir, saquinavir, delavirdine and efavirenz in human plasma

Journal of chromatography. B, Biomedical sciences and applications, 2000-06, Vol.742 (2), p.453-458

2000

Volltextzugriff (PDF)

Effect of Sofosbuvir/Daclatasvir ± Ribavirin on the Pharmacokinetics of Calcineurin Inhibitors in Liver Transplant Recipients – from the ANRS CO23 Cupilt Study

Journal of hepatology, 2016, Vol.64 (2), p.S507-S508

2016

Volltextzugriff (PDF)

Effect of selected antimalarial drugs and inhibitors of cytochrome P-450 3A4 on halofantrine metabolism by human liver microsomes

Drug metabolism and disposition, 1999-05, Vol.27 (5), p.565

1999

Volltextzugriff (PDF)

Halofantrine Metabolism in Microsomes in Man: Major Role of CYP 3A4 and CYP 3A5

Journal of pharmacy and pharmacology, 1999-04, Vol.51 (4), p.419-426

1999

Volltextzugriff (PDF)

P1237 ANTI-HEPATITIS C (HCV) TRIPLE THERAPY WITH PROTEASE INHIBITORS IN HIV/HCV CO-INFECTED PATIENTS AFTER LIVER TRANSPLANTATION

Journal of hepatology, 2014-04, Vol.60 (1), p.S501-S501

2014

Volltextzugriff (PDF)

Methadone is poorly removed by haemodialysis

Nephrology, dialysis, transplantation, 1999-01, Vol.14 (1), p.254-255

1999

Volltextzugriff (PDF)

Drug interactions with antiviral drugs

Clinical pharmacokinetics, 1996-05, Vol.30 (5), p.385-401

1996

Volltextzugriff (PDF)

Pharmacokinetic optimisation of asthma treatment

Clinical pharmacokinetics, 1994-05, Vol.26 (5), p.396-418

1994

Volltextzugriff (PDF)

Pharmacokinetics of tacrolimus (FK506) in paediatric liver transplant recipients

European journal of drug metabolism and pharmacokinetics, 1998-07, Vol.23 (3), p.367-370

1998

Volltextzugriff (PDF)

Penetration of foscarnet into cerebrospinal fluid of AIDS patients

Antimicrobial Agents and Chemotherapy, 1993-09, Vol.37 (9), p.1777-1780

1993

Volltextzugriff (PDF)

Pharmacokinetic Study of Raltegravir in HIV-Infected Patients With End-Stage Liver Disease: The LIVERAL-ANRS 148 Study

Clinical infectious diseases, 2014-10, Vol.59 (8), p.1177-1184

2014

Volltextzugriff (PDF)

Interaction Between Tacrolimus and Itraconazole in a Heart–Lung Transplant Recipient

Transplantation proceedings, 1998-02, Vol.30 (1), p.187-188

1998

Volltextzugriff (PDF)

1 – 25 von 196

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(160)
Mit Volltextzugriff
(154)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

Humans
(111)
Science & Technology
(109)
Life Sciences & Biomedicine
(100)
Biological And Medical Sciences
(79)
Medical Sciences
(78)
Pharmacology. Drug Treatments
(75)
Male
(71)
Adult
(62)
Female
(60)
Pharmacology & Pharmacy
(60)
Antibiotics. Antiinfectious Agents. Antiparasitic Agents
(53)
Hiv Infections - Drug Therapy
(49)
Middle Aged
(46)
Infectious Diseases
(40)
Antiviral Agents
(38)
Human Viral Diseases
(32)
Viral Diseases
(32)
Viral Diseases Of The Lymphoid Tissue And The Blood. Aids
(31)
Human Immunodeficiency Virus
(27)
Aids/hiv
(25)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

High Rate of Virologic Suppression with Raltegravir plus Etravirine and Darunavir/Ritonavir among Treatment-Experienced Patients Infected with Multidrug-Resistant HIV: Results of the ANRS 139 TRIO Trial

Effect of Adherence as Measured by MEMS, Ritonavir Boosting, and CYP3A5 Genotype on Atazanavir Pharmacokinetics in Treatment-Naive HIV-Infected Patients

Pharmacokinetics of Rifampin and Isoniazid in Tuberculosis-HIV-Coinfected Patients Receiving Nevirapine- or Efavirenz-Based Antiretroviral Treatment

Worsening pneumonitis due to a pharmacokinetic drug–drug interaction between everolimus and voriconazole in a renal transplant patient

Long-term efficacy of darunavir/ritonavir monotherapy in patients with HIV-1 viral suppression: week 96 results from the MONOI ANRS 136 study

Influence of Alpha-1 Glycoprotein Acid Concentrations and Variants on Atazanavir Pharmacokinetics in HIV-Infected Patients Included in the ANRS 107 Trial

Effect of coadministered HIV-protease inhibitors on tacrolimus and sirolimus blood concentrations in a kidney transplant recipients

Population pharmacokinetic analysis for nelfinavir and its metabolite M8 in virologically controlled HIV‐infected patients on HAART

In vitro effects of tacrolimus on human cytochrome P450

Single-Dose Pharmacokinetics of Amprenavir Coadministered with Grapefruit Juice

Interactions between Atazanavir-Ritonavir and Tenofovir in Heavily Pretreated Human Immunodeficiency Virus-Infected Patients

Therapeutic drug monitoring of methadone in HIV-infected patients receiving protease inhibitors

Simultaneous high-performance liquid chromatographic determination of the antiretroviral agents amprenavir, nelfinavir, ritonavir, saquinavir, delavirdine and efavirenz in human plasma

Effect of Sofosbuvir/Daclatasvir ± Ribavirin on the Pharmacokinetics of Calcineurin Inhibitors in Liver Transplant Recipients – from the ANRS CO23 Cupilt Study

Effect of selected antimalarial drugs and inhibitors of cytochrome P-450 3A4 on halofantrine metabolism by human liver microsomes

Halofantrine Metabolism in Microsomes in Man: Major Role of CYP 3A4 and CYP 3A5

P1237 ANTI-HEPATITIS C (HCV) TRIPLE THERAPY WITH PROTEASE INHIBITORS IN HIV/HCV CO-INFECTED PATIENTS AFTER LIVER TRANSPLANTATION

Methadone is poorly removed by haemodialysis

Drug interactions with antiviral drugs

Pharmacokinetic optimisation of asthma treatment

Pharmacokinetics of tacrolimus (FK506) in paediatric liver transplant recipients

Penetration of foscarnet into cerebrospinal fluid of AIDS patients

Pharmacokinetic Study of Raltegravir in HIV-Infected Patients With End-Stage Liver Disease: The LIVERAL-ANRS 148 Study

Interaction Between Tacrolimus and Itraconazole in a Heart–Lung Transplant Recipient

Raltegravir for the treatment of patients co-infected with HIV and tuberculosis (ANRS 12 180 Reflate TB): a multicentre, phase 2, non-comparative, open-label, randomised trial

Suchergebnisse filtern